{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:07:36Z","timestamp":1779066456172,"version":"3.51.4"},"publisher-location":"Cham","reference-count":51,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032218605","type":"print"},{"value":"9783032218612","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-21861-2_11","type":"book-chapter","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:18:31Z","timestamp":1779063511000},"page":"221-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Sam","family":"Pournezhad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramyar","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Taghizadeh-Hesary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"1","key":"11_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.12858","volume":"295","author":"L Makowski","year":"2020","unstructured":"Makowski L, Chaib M, Rathmell JC. Immunometabolism: from basic mechanisms to translation. Immunol Rev. 2020;295(1):5\u201314. https:\/\/doi.org\/10.1111\/imr.12858.","journal-title":"Immunol Rev"},{"key":"11_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114242","volume":"184","author":"T Khodaei","year":"2022","unstructured":"Khodaei T, Inamdar S, Suresh AP, Acharya AP. Drug delivery for metabolism targeted cancer immunotherapy. Adv Drug Deliv Rev. 2022;184:114242. https:\/\/doi.org\/10.1016\/j.addr.2022.114242.","journal-title":"Adv Drug Deliv Rev"},{"key":"11_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4273943","volume":"2016","author":"PH Pandya","year":"2016","unstructured":"Pandya PH, Murray ME, Pollok KE, Renbarger JL. The immune system in cancer pathogenesis: potential therapeutic approaches. J Immunol Res. 2016;2016:4273943. https:\/\/doi.org\/10.1155\/2016\/4273943.","journal-title":"J Immunol Res"},{"issue":"6","key":"11_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/cancers11060860","volume":"11","author":"J Boustani","year":"2019","unstructured":"Boustani J, Grapin M, Laurent P-A, Apetoh L, Mirjolet C. The 6th R of radiobiology: reactivation of anti-tumor immune response. Cancers (Basel). 2019;11(6):860. https:\/\/doi.org\/10.3390\/cancers11060860.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"11_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/s12887-024-05030-4","volume":"24","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zhang A, Liu A, Hu Q. Clinical analysis of immune reconstitution after chemotherapy in children with acute lymphoblastic leukemia. BMC Pediatr. 2024;24(1):557. https:\/\/doi.org\/10.1186\/s12887-024-05030-4.","journal-title":"BMC Pediatr"},{"key":"11_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9585614","volume":"2018","author":"J Koury","year":"2018","unstructured":"Koury J, et al. Immunotherapies: exploiting the immune system for cancer treatment. J Immunol Res. 2018;2018:9585614. https:\/\/doi.org\/10.1155\/2018\/9585614.","journal-title":"J Immunol Res"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.12688\/f1000research.9356.1","volume":"5","author":"RR Munhoz","year":"2016","unstructured":"Munhoz RR, Postow MA. Recent advances in understanding antitumor immunity. F1000Res. 2016;5:2545. https:\/\/doi.org\/10.12688\/f1000research.9356.1.","journal-title":"F1000Res"},{"issue":"3","key":"11_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ijrobp.2023.09.027","volume":"119","author":"F Taghizadeh-Hesary","year":"2024","unstructured":"Taghizadeh-Hesary F. \u2018Reinforcement\u2019 by tumor microenvironment: the seventh \u2018R\u2019 of radiobiology. Int J Radiat Oncol Biol Phys. 2024;119(3):727\u201333. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.027.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"11_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00005-023-00676-x","volume":"71","author":"D Ribatti","year":"2023","unstructured":"Ribatti D. Mast cells and resistance to immunotherapy in cancer. Arch Immunol Ther Exp. 2023;71(1):11. https:\/\/doi.org\/10.1007\/s00005-023-00676-x.","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"11_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12967-023-04418-7","volume":"21","author":"S Ghaffari","year":"2023","unstructured":"Ghaffari S, Rezaei N. Eosinophils in the tumor microenvironment: implications for cancer immunotherapy. J Transl Med. 2023;21(1):551. https:\/\/doi.org\/10.1186\/s12967-023-04418-7.","journal-title":"J Transl Med"},{"issue":"7","key":"11_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12032-025-02822-1","volume":"42","author":"MR Zamani","year":"2025","unstructured":"Zamani MR, \u0160\u00e1cha P. Immune checkpoint inhibitors in cancer therapy: what lies beyond monoclonal antibodies? Med Oncol. 2025;42(7):273. https:\/\/doi.org\/10.1007\/s12032-025-02822-1.","journal-title":"Med Oncol"},{"issue":"8","key":"11_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30(8):660\u20139. https:\/\/doi.org\/10.1038\/s41422-020-0343-4.","journal-title":"Cell Res"},{"issue":"3","key":"11_CR13","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/med.21771","volume":"41","author":"L You","year":"2021","unstructured":"You L, et al. The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev. 2021;41(3):1622\u201343. https:\/\/doi.org\/10.1002\/med.21771.","journal-title":"Med Res Rev"},{"issue":"11","key":"11_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41401-020-00500-8","volume":"41","author":"P Sun","year":"2020","unstructured":"Sun P, Meng L. Emerging roles of class I PI3K inhibitors in modulating tumor microenvironment and immunity. Acta Pharmacol Sin. 2020;41(11):1395\u2013402. https:\/\/doi.org\/10.1038\/s41401-020-00500-8.","journal-title":"Acta Pharmacol Sin"},{"issue":"7718","key":"11_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560(7718):382\u20136. https:\/\/doi.org\/10.1038\/s41586-018-0392-8.","journal-title":"Nature"},{"issue":"1","key":"11_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha T, et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat Nanotechnol. 2022;17(1):98\u2013106. https:\/\/doi.org\/10.1038\/s41565-021-01000-4.","journal-title":"Nat Nanotechnol"},{"issue":"8049","key":"11_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","volume":"638","author":"H Ikeda","year":"2025","unstructured":"Ikeda H, et al. Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature. 2025;638(8049):225\u201336. https:\/\/doi.org\/10.1038\/s41586-024-08439-0.","journal-title":"Nature"},{"key":"11_CR18","doi-asserted-by":"publisher","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6(6):\u2013e1792. https:\/\/doi.org\/10.1038\/cddis.2015.162.","DOI":"10.1038\/cddis.2015.162"},{"issue":"1","key":"11_CR19","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming. Nat Commun. 2023;14(1):6858. https:\/\/doi.org\/10.1038\/s41467-023-42634-3.","journal-title":"Nat Commun"},{"issue":"1","key":"11_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol. 2016;39(1):98\u2013106. https:\/\/doi.org\/10.1097\/COC.0000000000000239.","journal-title":"Am J Clin Oncol"},{"issue":"18","key":"11_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14186680","volume":"14","author":"F Petrelli","year":"2025","unstructured":"Petrelli F, et al. Immune checkpoint inhibitors beyond progression in various solid tumors: a systematic review and pooled analysis. JCM. 2025;14(18):6680. https:\/\/doi.org\/10.3390\/jcm14186680.","journal-title":"JCM"},{"issue":"4","key":"11_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","volume":"43","author":"B Du","year":"2025","unstructured":"Du B, Qin J, Lin B, Zhang J, Li D, Liu M. CAR-T therapy in solid tumors. Cancer Cell. 2025;43(4):665\u201379. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.019.","journal-title":"Cancer Cell"},{"issue":"1","key":"11_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s44272-025-00039-x","volume":"4","author":"C Wang","year":"2025","unstructured":"Wang C, Hao P. Therapeutic vaccine strategies in cancer: advances, challenges, and future directions. Clin Cancer Bull. 2025;4(1):10. https:\/\/doi.org\/10.1007\/s44272-025-00039-x.","journal-title":"Clin Cancer Bull"},{"issue":"4","key":"11_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","volume":"30","author":"M Yarchoan","year":"2024","unstructured":"Yarchoan M, et al. Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial. Nat Med. 2024;30(4):1044\u201353. https:\/\/doi.org\/10.1038\/s41591-024-02894-y.","journal-title":"Nat Med"},{"issue":"1","key":"11_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41467-023-44308-6","volume":"15","author":"J Middelburg","year":"2024","unstructured":"Middelburg J, et al. T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors. Nat Commun. 2024;15(1):48. https:\/\/doi.org\/10.1038\/s41467-023-44308-6.","journal-title":"Nat Commun"},{"issue":"10","key":"11_CR26","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41590-025-02252-1","volume":"26","author":"MS Eggeb\u00f8","year":"2025","unstructured":"Eggeb\u00f8 MS, et al. TCR-engineered T cells targeting a shared \u03b2-catenin mutation eradicate solid tumors. Nat Immunol. 2025;26(10):1726\u201336. https:\/\/doi.org\/10.1038\/s41590-025-02252-1.","journal-title":"Nat Immunol"},{"issue":"1","key":"11_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10238-025-01559-5","volume":"25","author":"M Rady","year":"2025","unstructured":"Rady M, Mostafa M, Dida G, Sabet F, Abou-Aisha K, Watzl C. Adoptive NK cell therapy in AML: progress and challenges. Clin Exp Med. 2025;25(1):41. https:\/\/doi.org\/10.1007\/s10238-025-01559-5.","journal-title":"Clin Exp Med"},{"issue":"1","key":"11_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mco2.6","volume":"1","author":"R Shi","year":"2020","unstructured":"Shi R, Tang Y-Q, Miao H. Metabolism in tumor microenvironment: implications for cancer immunotherapy. Med Comm (2020). 2020;1(1):47\u201368. https:\/\/doi.org\/10.1002\/mco2.6.","journal-title":"Med Comm (2020)"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2025.05.003","volume":"197","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, et al. Advances in the mechanisms of HIF-1\u03b1-enhanced tumor glycolysis and its relation to dedifferentiation. Prog Biophys Mol Biol. 2025;197:1\u201310. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2025.05.003.","journal-title":"Prog Biophys Mol Biol"},{"key":"11_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156271","volume":"276","author":"D Devi","year":"2025","unstructured":"Devi D, et al. Hypoxia-driven metabolic and molecular reprogramming: from tumor microenvironment to therapeutic interventions. Pathol Res Pract. 2025;276:156271. https:\/\/doi.org\/10.1016\/j.prp.2025.156271.","journal-title":"Pathol Res Pract"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.semcancer.2022.07.005","volume":"86","author":"H Lee","year":"2022","unstructured":"Lee H, Woo SM, Jang H, Kang M, Kim S-Y. Cancer depends on fatty acids for ATP production: a possible link between cancer and obesity. Semin Cancer Biol. 2022;86:347\u201357. https:\/\/doi.org\/10.1016\/j.semcancer.2022.07.005.","journal-title":"Semin Cancer Biol"},{"key":"11_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103627","volume":"73","author":"Z-H Wang","year":"2021","unstructured":"Wang Z-H, Peng W-B, Zhang P, Yang X-P, Zhou Q. Lactate in the tumour microenvironment: from immune modulation to therapy. EBioMedicine. 2021;73:103627. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103627.","journal-title":"EBioMedicine"},{"issue":"10","key":"11_CR33","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1158\/0008-5472.CAN-05-4193","volume":"66","author":"RA Gatenby","year":"2006","unstructured":"Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 2006;66(10):5216\u201323. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4193.","journal-title":"Cancer Res"},{"issue":"6","key":"11_CR34","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/mp200292c","volume":"8","author":"JW Wojtkowiak","year":"2011","unstructured":"Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm. 2011;8(6):2032\u20138. https:\/\/doi.org\/10.1021\/mp200292c.","journal-title":"Mol Pharm"},{"issue":"19","key":"11_CR35","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","volume":"72","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. 2012;72(19):5130\u201340. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1949.","journal-title":"Cancer Res"},{"issue":"3","key":"11_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/imm.12917","volume":"154","author":"S Damgaci","year":"2018","unstructured":"Damgaci S, Ibrahim-Hashim A, Enriquez-Navas PM, Pilon-Thomas S, Guvenis A, Gillies RJ. Hypoxia and acidosis: immune suppressors and therapeutic targets. Immunology. 2018;154(3):354\u201362. https:\/\/doi.org\/10.1111\/imm.12917.","journal-title":"Immunology"},{"issue":"6","key":"11_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010151","volume":"13","author":"Y Yu","year":"2025","unstructured":"Yu Y, et al. Hypoxia upregulates the expression of PD-L1 via NPM1 in breast cancer. J Immunother Cancer. 2025;13(6):e010151. https:\/\/doi.org\/10.1136\/jitc-2024-010151.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"11_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","volume":"8","author":"DK-C Chiu","year":"2017","unstructured":"Chiu DK-C, et al. Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma. Nat Commun. 2017;8(1):517. https:\/\/doi.org\/10.1038\/s41467-017-00530-7.","journal-title":"Nat Commun"},{"issue":"2","key":"11_CR39","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/bcr2869","volume":"13","author":"M Yan","year":"2011","unstructured":"Yan M, et al. Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers. Breast Cancer Res. 2011;13(2):R47. https:\/\/doi.org\/10.1186\/bcr2869.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"11_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.humimm.2022.02.007","volume":"83","author":"KK Goswami","year":"2022","unstructured":"Goswami KK, Banerjee S, Bose A, Baral R. Lactic acid in alternative polarization and function of macrophages in tumor microenvironment. Hum Immunol. 2022;83(5):409\u201317. https:\/\/doi.org\/10.1016\/j.humimm.2022.02.007.","journal-title":"Hum Immunol"},{"issue":"17","key":"11_CR41","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/cancers16173044","volume":"16","author":"F Taghizadeh-Hesary","year":"2024","unstructured":"Taghizadeh-Hesary F, Ghadyani M, Kashanchi F, Behnam B. Exploring TSGA10 function: a crosstalk or controlling mechanism in the signaling pathway of carcinogenesis? Cancers (Basel). 2024;16(17):3044. https:\/\/doi.org\/10.3390\/cancers16173044.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"11_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370. https:\/\/doi.org\/10.1016\/s0092-8674(00)81683-9.","journal-title":"Cell"},{"issue":"5","key":"11_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"1","key":"11_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"issue":"9","key":"11_CR45","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","volume":"20","author":"RD Leone","year":"2020","unstructured":"Leone RD, Powell JD. Metabolism of immune cells in cancer. Nat Rev Cancer. 2020;20(9):516\u201331. https:\/\/doi.org\/10.1038\/s41568-020-0273-y.","journal-title":"Nat Rev Cancer"},{"issue":"8075","key":"11_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41586-025-09176-8","volume":"644","author":"G Hoover","year":"2025","unstructured":"Hoover G, et al. Nerve-to-cancer transfer of mitochondria during cancer metastasis. Nature. 2025;644(8075):252\u201362. https:\/\/doi.org\/10.1038\/s41586-025-09176-8.","journal-title":"Nature"},{"issue":"9","key":"11_CR47","doi-asserted-by":"publisher","first-page":"15539","DOI":"10.18632\/oncotarget.14695","volume":"8","author":"J Lu","year":"2017","unstructured":"Lu J, et al. Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells. Oncotarget. 2017;8(9):15539\u201352. https:\/\/doi.org\/10.18632\/oncotarget.14695.","journal-title":"Oncotarget"},{"issue":"14","key":"11_CR48","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260419","volume":"136","author":"KF Goliwas","year":"2023","unstructured":"Goliwas KF, et al. Mitochondrial transfer from cancer-associated fibroblasts increases migration in aggressive breast cancer. J Cell Sci. 2023;136(14):jcs260419. https:\/\/doi.org\/10.1242\/jcs.260419.","journal-title":"J Cell Sci"},{"issue":"5","key":"11_CR49","doi-asserted-by":"publisher","first-page":"E761","DOI":"10.1073\/pnas.1620433114","volume":"114","author":"K Chamoto","year":"2017","unstructured":"Chamoto K, et al. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci USA. 2017;114(5):E761\u201370. https:\/\/doi.org\/10.1073\/pnas.1620433114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"11_CR50","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.cmet.2017.09.006","volume":"26","author":"S Andrzejewski","year":"2017","unstructured":"Andrzejewski S, et al. PGC-1\u03b1 promotes breast cancer metastasis and confers bioenergetic flexibility against metabolic drugs. Cell Metab. 2017;26(5):778\u201387.e5. https:\/\/doi.org\/10.1016\/j.cmet.2017.09.006.","journal-title":"Cell Metab"},{"issue":"7","key":"11_CR51","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1080\/15476286.2019.1600999","volume":"16","author":"PK Purohit","year":"2019","unstructured":"Purohit PK, Edwards R, Tokatlidis K, Saini N. MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells. RNA Biol. 2019;16(7):918\u201329. https:\/\/doi.org\/10.1080\/15476286.2019.1600999.","journal-title":"RNA Biol"}],"container-title":["Cancer Treatment and Research","Cancer Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-21861-2_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:18:32Z","timestamp":1779063512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-21861-2_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032218605","9783032218612"],"references-count":51,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-21861-2_11","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}